Vytorin Tablet
Product Images NDC 78206-175

7 FDA label images from Organon Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vytorin (NDC 78206-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vytorin 01)

Chemical Structure (Vytorin 01)
Chemical structure of the active ingredients ezetimibe and simvastatin shown as molecular diagrams with multiple aromatic rings, hydroxyl groups, and fluorine atoms.*
FDA Label Image

Chemical Structure (Vytorin 02)

Chemical Structure (Vytorin 02)
Chemical structure diagram of the active ingredient in VYTORIN, ezetimibe and simvastatin, showing the molecular configuration and bonds.*
FDA Label Image

Figure 1 (Vytorin 03)

Figure 1 (Vytorin 03)
A line graph depicting major vascular events over a 5-year follow-up period comparing placebo (solid line) and VYTORIN (dashed line). The y-axis represents the percentage of patients with events, and the x-axis shows years of follow-up. A log-rank test with P=0.001 is noted. Below the graph are patient counts at risk for both placebo and VYTORIN groups at multiple time points.*
FDA Label Image

Principal Display Panel (10 mg /10 mg Tablet Bottle Label)

Principal Display Panel (10 mg /10 mg Tablet Bottle Label)
Vytorin 10 mg/10 mg tablets packaging label showing the active ingredients ezetimibe and simvastatin. The label indicates each tablet contains 10 mg of both ezetimibe and simvastatin. It includes storage instructions, a barcode, and states the package contains 30 tablets. The labeler is Organon LLC.*
FDA Label Image

Principal Display Panel (10 mg /20 mg Tablet Bottle Label)

Principal Display Panel (10 mg /20 mg Tablet Bottle Label)
Vytorin 10 mg / 20 mg tablets packaging label showing the active ingredients ezetimibe and simvastatin. The label indicates the quantity of 30 tablets and includes dosage information, manufacturer Organon LLC, barcodes, and storage instructions. The label also reserves space for 2D serialization barcode, serial number, expiry, and lot details.*
FDA Label Image

Principal Display Panel (10 mg /40 mg Tablet Bottle Label)

Principal Display Panel (10 mg /40 mg Tablet Bottle Label)
Label for Vytorin tablets containing 10 mg ezetimibe and 40 mg simvastatin. The label shows the product name, strengths, dosage form, and that it is prescription only. It includes a barcode, the Organon LLC logo, and indicates a package size of 30 tablets.*
FDA Label Image

Principal Display Panel (10 mg /80 mg Tablet Bottle Label)

Principal Display Panel (10 mg /80 mg Tablet Bottle Label)
VYTORIN 10 mg / 80 mg tablets label showing the combination of ezetimibe and simvastatin in oral tablet form. The label includes dosage strength, tablet image imprinted with '315', quantity of 30 tablets, manufacturer Organon LLC, and a barcode. Storage instructions and prescription-only status are visible, with designated space for serialization and lot details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.